NewsBenzingaCastle Biosciences wird auf dem EADV-Kongress 2026 neue Daten zu DecisionDx-Melanoma präsentieren Castle Biosciences wird auf dem EADV-Kongress 2026 neue Daten zu DecisionDx-Melanoma präsentieren Benzinga 2026.09.30 20:32 (GMT+0) Open on Benzinga Other news Important News from Last Night and This Morning (October 19–October 20) Stock Pickers Burned by the AI Boom Think Their Moment Has Finally Arrived Walmart’s Flipkart is quietly building a food delivery challenger in India Robotics AI Company Dream Labs Completes $90 Million Seed Round, Launches Robot Foundation Model API Elysium, an L2 network in the Hyperliquid ecosystem, to launch mainnet on November 9 ARK Invest buys about $8.1 million of CoreWeave stock, sells about $3.56 million of Palantir stock
